‘Multicopy Multivalent’ Glycopolymer-Stabilized Gold Nanoparticles as Potential Synthetic Cancer Vaccines

Mucin-related carbohydrates are overexpressed on the surface of cancer cells, providing a disease-specific target for cancer immunotherapy. Here, we describe the design and construction of peptide-free multivalent glycosylated nanoscale constructs as potential synthetic cancer vaccines that generate significant titers of antibodies selective for aberrant mucin glycans. A polymerizable version of the Tn-antigen glycan was prepared and converted into well-defined glycopolymers by Reversible Addition–Fragmentation chain Transfer (RAFT) polymerization. The polymers were then conjugated to gold nanoparticles, yielding ‘multicopy-multivalent’ nanoscale glycoconjugates. Immunological studies indicated that these nanomaterials generated strong and long-lasting production of antibodies that are selective to the Tn-antigen glycan and cross-reactive toward mucin proteins displaying Tn. The results demonstrate proof-of-concept of a simple and modular approach toward synthetic anticancer vaccines based on multivalent glycosylated nanomaterials without the need for a typical vaccine protein component.

[1]  E. Schmitt,et al.  Fully synthetic vaccines consisting of tumor-associated MUC1 glycopeptides and a lipopeptide ligand of the Toll-like receptor 2. , 2010, Angewandte Chemie.

[2]  G. Moad,et al.  Toward living radical polymerization. , 2008, Accounts of chemical research.

[3]  K. Kontturi,et al.  Amphiphilic Gold Nanoparticles Grafted with Poly(N-isopropylacrylamide) and Polystyrene , 2005 .

[4]  V. Ladmiral,et al.  Synthetic glycopolymers: an overview , 2004 .

[5]  J. Barchi,et al.  Design and synthesis of multifunctional gold nanoparticles bearing tumor-associated glycopeptide antigens as potential cancer vaccines. , 2012, Bioconjugate chemistry.

[6]  Allen,et al.  From the Laboratory to the Clinic: A Retrospective on Fully Synthetic Carbohydrate-Based Anticancer Vaccines Frequently used abbreviations are listed in the appendix. , 2000, Angewandte Chemie.

[7]  G. Boons,et al.  Towards a fully synthetic carbohydrate-based anticancer vaccine: synthesis and immunological evaluation of a lipidated glycopeptide containing the tumor-associated tn antigen. , 2005, Angewandte Chemie.

[8]  N. Cameron,et al.  A spoonful of sugar: the application of glycopolymers in therapeutics , 2011 .

[9]  S. Kuduk,et al.  Synthetic and Immunological Studies on Clustered Modes of Mucin-Related Tn and TF O-Linked Antigens: The Preparation of a Glycopeptide-Based Vaccine for Clinical Trials against Prostate Cancer† , 1998 .

[10]  M. Peyton,et al.  Immunization of ovarian cancer patients with a synthetic Lewisy‐protein conjugate vaccine: A phase 1 trial , 2000, International journal of cancer.

[11]  A. Iasonos,et al.  Pilot Study of a Heptavalent Vaccine-Keyhole Limpet Hemocyanin Conjugate plus QS21 in Patients with Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer , 2007, Clinical Cancer Research.

[12]  Zhongwu Guo,et al.  Recent development in carbohydrate-based cancer vaccines. , 2009, Current opinion in chemical biology.

[13]  S. Penadés,et al.  Preparation of multifunctional glyconanoparticles as a platform for potential carbohydrate-based anticancer vaccines. , 2007, Carbohydrate research.

[14]  H. Scher,et al.  Thomsen-Friedenreich (TF) antigen as a target for prostate cancer vaccine: clinical trial results with TF cluster (c)-KLH plus QS21 conjugate vaccine in patients with biochemically relapsed prostate cancer , 2005, Cancer Immunology, Immunotherapy.

[15]  S. Thompson,et al.  DPPE: A convenient replacement for triphynylphosphine in the staudinger and Mitsunobu reactions , 1998 .

[16]  E. Schmitt,et al.  Synthetic antitumor vaccines from tetanus toxoid conjugates of MUC1 glycopeptides with the Thomsen-Friedenreich antigen and a fluorine-substituted analogue. , 2010, Angewandte Chemie.

[17]  A. Bernad,et al.  Gold Glyconanoparticles as New Tools in Antiadhesive Therapy , 2004, Chembiochem : a European journal of chemical biology.

[18]  J. D. Dal Porto,et al.  B cell antigen receptor signaling 101. , 2004, Molecular immunology.

[19]  N. Sibson,et al.  Glyconanoparticles allow pre-symptomatic in vivo imaging of brain disease , 2009, Proceedings of the National Academy of Sciences.

[20]  E. Schmitt,et al.  Synthetic vaccines consisting of tumor-associated MUC1 glycopeptide antigens and a T-cell epitope for the induction of a highly specific humoral immune response. , 2008, Angewandte Chemie.

[21]  H. Jiang,et al.  Synthesis of Gold Nanoparticles Grafted with a Thermoresponsive Polymer by Surface-Induced Reversible-Addition-Fragmentation Chain-Transfer Polymerization , 2003 .

[22]  Malcolm L. H. Green,et al.  Filled and glycosylated carbon nanotubes for in vivo radioemitter localization and imaging. , 2010, Nature materials.

[23]  J. J. Steinberg,et al.  Effects of desialylation of ovine submaxillary gland mucin (OSM) on humoral and cellular immune responses to Tn and sialylated Tn. , 2006, Cancer immunity.

[24]  B. Sumerlin,et al.  Facile preparation of transition metal nanoparticles stabilized by well-defined (co)polymers synthesized via aqueous reversible addition-fragmentation chain transfer polymerization. , 2002, Journal of the American Chemical Society.

[25]  Graeme Moad,et al.  Radical addition-fragmentation chemistry in polymer synthesis , 2008 .

[26]  J. Chiefari,et al.  Living free-radical polymerization by reversible addition - Fragmentation chain transfer: The RAFT process , 1998 .

[27]  H. Kunz,et al.  Synthetic vaccines of tumor-associated glycopeptide antigens by immune-compatible thioether linkage to bovine serum albumin. , 2007, Angewandte Chemie.

[28]  H. Scher,et al.  Carbohydrate vaccines in cancer: immunogenicity of a fully synthetic globo H hexasaccharide conjugate in man. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[29]  T. Kurosaki.  Regulation of B cell fates by BCR signaling components. , 2002, Current opinion in immunology.

[30]  Zhenqing Zhang,et al.  Effect and limitation of excess ammonium on the release of O-glycans in reducing forms from glycoproteins under mild alkaline conditions for glycomic and functional analysis. , 2010, Analytical chemistry.

[31]  Yan‐Mei Li,et al.  Towards a fully synthetic MUC1-based anticancer vaccine: efficient conjugation of glycopeptides with mono-, di-, and tetravalent lipopeptides using click chemistry. , 2011, Chemistry.

[32]  Larry Norton,et al.  Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: A phase I trial , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[33]  M. Wolfert,et al.  Robust immune responses elicited by a fully synthetic three-component vaccine. , 2007, Nature chemical biology.

[34]  J. Angulo,et al.  Gold nanoparticles coated with oligomannosides of HIV-1 glycoprotein gp120 mimic the carbohydrate epitope of antibody 2G12. , 2011, Journal of molecular biology.

[35]  I. García,et al.  Glyconanoparticles: multifunctional nanomaterials for biomedical applications. , 2010, Nanomedicine.

[36]  M. Kris,et al.  Vaccination of Patients with Small-Cell Lung Cancer with Synthetic Fucosyl GM-1 Conjugated to Keyhole Limpet Hemocyanin , 2004, Clinical Cancer Research.

[37]  J. M. de la Fuente,et al.  Glyconanoparticles: types, synthesis and applications in glycoscience, biomedicine and material science. , 2006, Biochimica et biophysica acta.

[38]  J. Barchi,et al.  Varied presentation of the Thomsen-Friedenreich disaccharide tumor-associated carbohydrate antigen on gold nanoparticles. , 2008, Carbohydrate research.

[39]  S. Penadés,et al.  A model system mimicking glycosphingolipid clusters to quantify carbohydrate self-interactions by surface plasmon resonance. , 2002, Angewandte Chemie.

[40]  J. Rojo,et al.  Gold Glyconanoparticles as Water-Soluble Polyvalent Models To Study Carbohydrate Interactions. , 2001, Angewandte Chemie.

[41]  N. Cameron,et al.  Recent advances in the synthesis of well-defined glycopolymers , 2007 .

[42]  S. Pinder,et al.  Over-expression of ST3Gal-I promotes mammary tumorigenesis , 2010, Glycobiology.

[43]  S. Danishefsky,et al.  A new model for the presentation of tumor-associated antigens and the quest for an anticancer vaccine: a solution to the synthesis challenge via ring-closing metathesis. , 2009, Journal of the American Chemical Society.

[44]  M. Menéndez,et al.  Thermodynamic evidence for Ca2+-mediated self-aggregation of Lewis X gold glyconanoparticles. A model for cell adhesion via carbohydrate-carbohydrate interaction. , 2005, Journal of the American Chemical Society.

[45]  S. Svarovsky,et al.  Synthesis of gold nanoparticles bearing the Thomsen–Friedenreich disaccharide: a new multivalent presentation of an important tumor antigen , 2005 .

[46]  P. Wakeley,et al.  Synthesis , 2013, The Role of Animals in Emerging Viral Diseases.

[47]  G. Boons,et al.  Immunotherapy for cancer: synthetic carbohydrate-based vaccines. , 2009, Chemical communications.

[48]  S. Penadés,et al.  Gold glyconanoparticles: synthetic polyvalent ligands mimicking glycocalyx-like surfaces as tools for glycobiological studies. , 2003, Chemistry.

[49]  Gaojian Chen,et al.  Synthesis of glycopolymers and their multivalent recognitions with lectins , 2010 .